The murine autoimmune diabetes model: NOD and related strains

Adv Immunol. 1992;51:285-322. doi: 10.1016/s0065-2776(08)60490-3.
No abstract available

Publication types

  • Review

MeSH terms

  • Adjuvants, Immunologic / therapeutic use
  • Animals
  • Autoantigens / immunology
  • Autoimmune Diseases / genetics
  • Autoimmune Diseases / immunology*
  • Autoimmune Diseases / pathology
  • Autoimmune Diseases / therapy
  • B-Lymphocytes / immunology
  • B-Lymphocytes / pathology
  • Cytokines / therapeutic use
  • Diabetes Mellitus, Type 1 / genetics
  • Diabetes Mellitus, Type 1 / immunology*
  • Diabetes Mellitus, Type 1 / pathology
  • Disease Susceptibility / immunology
  • Female
  • Genes, MHC Class I
  • Genes, MHC Class II
  • Genetic Markers
  • Genetic Predisposition to Disease
  • H-2 Antigens / genetics
  • H-2 Antigens / immunology
  • Histocompatibility Antigens Class II / genetics
  • Histocompatibility Antigens Class II / immunology
  • Immunosuppressive Agents / therapeutic use
  • Macrophages / immunology
  • Macrophages / pathology
  • Male
  • Mice
  • Mice, Inbred NOD* / genetics
  • Mice, Inbred NOD* / metabolism
  • Mice, Transgenic / immunology
  • Rats
  • Rats, Inbred BB / genetics
  • Rats, Inbred BB / immunology
  • Streptozocin
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / pathology
  • T-Lymphocytes, Regulatory / immunology
  • T-Lymphocytes, Regulatory / pathology

Substances

  • Adjuvants, Immunologic
  • Autoantigens
  • Cytokines
  • Genetic Markers
  • H-2 Antigens
  • Histocompatibility Antigens Class II
  • I-E-antigen
  • Immunosuppressive Agents
  • Streptozocin